GE
Generate Biomedicines, Inc. (GENB)
NASDAQ·Healthcare·Biotechnology
$15.78
+2.57%
Mkt Cap $2.10B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (2 analysts)
$23.50
Range $22.00 – $25.00
Implied Upside
+48.9%
Consensus $23.50 vs current $15.78
NASDAQ·Healthcare·Biotechnology
$15.78
+2.57%
Mkt Cap $2.10B
Buy
4
Hold
0
Sell
0
Price Target (2 analysts)
$23.50
Range $22.00 – $25.00
+48.9%
Consensus $23.50 vs current $15.78